ABBV three-lens brief
Evidence-based stock research on ABBV. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 17.8pp over 30 days. · P/E of 102 — priced for high growth; little margin of safety.
- Underperforming SPY by 17.8pp over 30 days.
- P/E of 102 — priced for high growth; little margin of safety.
- Analyst mean target $252.23 — 21% above current (30 analysts).
ABBV closed at $207.86 (0.00%) as of 2026-05-13. Market cap: $367.25B. P/E (trailing) 101.9. Positives: analyst mean target $252.23 — 21% above current (30 analysts).. Concerns: underperforming SPY by 17.8pp over 30 days.; p/E of 102 — priced for high growth; little margin of safety.. Last quarter: Revenue $15.00B, net income $695.00M, free cash flow $20.81B.
Why three lenses on ABBV, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ABBVacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ABBV" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ABBV brief"></iframe>